Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0000899243-21-006355

Options or other derivatives

  • SVP, General Counsel and Sec acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sandercock Colin SVP, General Counsel and Sec 2021-02-10 Grant or award · Stock Option (right to buy) +50,000 50,000 D
Loading xslF345X03/doc4.xml…